ABBV - AbbVie Inc.
202.08
-1.610 -0.797%
Share volume: 5,787,090
Last Updated: Fri 21 Feb 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.34%
PREVIOUS CLOSE
CHG
CHG%
$203.69
1.20
0.01%
Summary score
50%
Profitability
62%
Dept financing
27%
Liquidity
15%
Performance
52%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
20.29%
Return on assets
2.11%
Return on sales
26.43%
Return on invested capital
3.23%
Total debt ratio
91.54%
Debt ratio change over timeo
32.88%
Current Ratio
0.86%
Quick Ratio
0.76%
Cash Position Ratio
0.29%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
1%
Return on sales
16.75%
Return on invested capital
0%
Total debt ratio
95.8%
Debt ratio change over timeo
0%
Current Ratio
0.76%
Quick Ratio
0.66%
Cash Position Ratio
0.26%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-1.23%
Return on sales
-9.87%
Return on invested capital
0%
Total debt ratio
97.54%
Debt ratio change over time
0%
Current Ratio
0.66%
Quick Ratio
0.55%
Cash Position Ratio
0.14%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
971.87%
Return on assets
21.03%
Return on sales
1166.76%
Return on invested capital
63.43%
Total debt ratio
3287.69%
Debt ratio change over time
32.88%
Current Ratio
33.89%
Quick Ratio
29.94%
Cash Position Ratio
12.2%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ABBV | AMGN | VRTX | GILD |
|---|---|---|---|---|
| Return on equity | 20.29% | 18.63% | 3.97% | 4.21% |
| Return on assets | 2.11% | 3.07% | 5.63% | 3.09% |
| Return on sales | 26.43% | 30.43% | 42.4% | 28.65% |
| Return on invested capital | 3.23% | 5.33% | 27.97% | 2.16% |
| Profitability | 53% | 59% | 80% | 38% |
| Total debt ratio | 91.54% | 92.23% | 24.37% | 67.38% |
| Debt ratio change over time | 32.88% | 18.13% | 0.01% | 116.87% |
| Dept financing | 32% | 29% | 7% | 43% |
| Current Ratio | 0.76% | 1.32% | 2.83% | 1.14% |
| Quick Ratio | 0.66% | 0.95% | 2.58% | 0.98% |
| Cash Position Ratio | 0.26% | 0.47% | 1.88% | 0.38% |
| Liquididy | 12% | 26% | 75% | 19% |
| Short-term ratios | ABBV | AMGN | VRTX | GILD |
|---|---|---|---|---|
| Return on equity | 0% | 0% | -9.2% | -23.78% |
| Return on assets | 1% | 2.13% | 4.89% | 0.73% |
| Return on sales | 16.75% | 21.39% | 40.27% | 4.66% |
| Return on invested capital | 0% | 0% | -15.46% | -14.26% |
| Profitability | 66% | 24% | 50% | 7% |
| Total debt ratio | 95.8% | 93.35% | 26.26% | 67.42% |
| Debt ratio change over time | 0% | 0% | -0.91% | 8.62% |
| Dept financing | 25% | 24% | 7% | 43% |
| Current Ratio | 0.76% | 1.32% | 2.83% | 1.14% |
| Quick Ratio | 0.66% | 0.95% | 2.58% | 0.98% |
| Cash Position Ratio | 0.26% | 0.47% | 1.88% | 0.38% |
| Liquididy | 17% | 27% | 75% | 25% |